First Trust Advisors’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-34,745
Closed -$109K 2485
2023
Q2
$109K Buy
34,745
+276
+0.8% +$997 ﹤0.01% 2327
2023
Q1
$180K Buy
34,469
+2,194
+7% +$15.8K ﹤0.01% 2314
2022
Q4
$239K Sell
32,275
-2,126
-6% -$19.2K ﹤0.01% 2344
2022
Q3
$431K Buy
+34,401
New +$411K ﹤0.01% 2254

Other funds holding SRTS

First Trust Advisors's SRTS Position: Q3 2023 in Review

First Trust Advisors sold out of Sensus Healthcare (SRTS) in Q3 2023, closing a stake of 34,745 shares — an estimated $109K sold.

First Trust Advisors first reported a position in SRTS in Q3 2022 and held it in 4 quarters. The position peaked at $431K in Q3 2022. 40 funds tracked by Wall St. Rank hold SRTS as of Q3 2023.

  • First Trust Advisors reported no remaining Sensus Healthcare position as of Q3 2023 after selling out during the quarter.
  • First Trust Advisors sold 34,745 Sensus Healthcare shares in Q3 2023, an estimated $109K.
  • First Trust Advisors first reported a position in Sensus Healthcare in Q3 2022 and held it in 4 quarters.
  • First Trust Advisors's Sensus Healthcare position peaked at $431K in Q3 2022.
  • 40 funds tracked by Wall St. Rank held Sensus Healthcare as of Q3 2023.

Based on First Trust Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.